Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics

References

• Demarest SJ, Hariharan K, Dong J. Emerging antibody combinations in oncology. MAbs 2011; 3:338 - 51; http://dx.doi.org/10.4161/mabs.3.4.16615; PMID: 21697653
   PubMed Web of Science ®Google Scholar
• Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 2008; 26:5922 - 7; http://dx.doi.org/10.1016/j.vaccine.2008.08.050; PMID: 18804136
   PubMed Web of Science ®Google Scholar
• Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr., Leney M, Sloan S, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010; 362:197 - 205; http://dx.doi.org/10.1056/NEJMoa0907635; PMID: 20089970
   PubMed Web of Science ®Google Scholar
• Meng Q, Li M, Silberg MA, Conrad F, Bettencourt J, To R, Huang C, Ma J, Meyer K, Shimizu R, et al. Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein. Anal Biochem 2012; 421:351 - 61; http://dx.doi.org/10.1016/j.ab.2011.09.030; PMID: 22037290
   PubMed Web of Science ®Google Scholar
• Cheung GY, Otto M. The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets 2012; 16:601 - 12; http://dx.doi.org/10.1517/14728222.2012.682573; PMID: 22530584
   PubMed Web of Science ®Google Scholar
• Alzabin S, Abraham SM, Taher TE, Palfreeman A, Hull D, McNamee K, Jawad A, Pathan E, Kinderlerer A, Taylor PC, et al. Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway. Ann Rheum Dis 2012; 71:1741 - 8; http://dx.doi.org/10.1136/annrheumdis-2011-201024; PMID: 22550316
   PubMed Web of Science ®Google Scholar
• Both L, Banyard AC, van Dolleweerd C, Wright E, Ma JK, Fooks AR. Monoclonal antibodies for prophylactic and therapeutic use against viral infections. Vaccine 2013; 31:1553 - 9; http://dx.doi.org/10.1016/j.vaccine.2013.01.025; PMID: 23370150
   PubMed Web of Science ®Google Scholar
• Hiatt A, Zeitlin L, Whaley KJ. Multiantibody strategies for HIV. Clin Dev Immunol 2013; 2013:632893; http://dx.doi.org/10.1155/2013/632893; PMID: 23840243
   PubMed Web of Science ®Google Scholar
• Prabakaran M, Prabhu N, He F, Hongliang Q, Ho HT, Qiang J, Meng T, Goutama M, Kwang J. Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants. PLoS One 2009; 4:e5672; http://dx.doi.org/10.1371/journal.pone.0005672; PMID: 19478856
   PubMed Web of Science ®Google Scholar
• ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med 2006; 3:e237; http://dx.doi.org/10.1371/journal.pmed.0030237; PMID: 16796401
   PubMed Web of Science ®Google Scholar
• Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, Mouquet H, Spatz LA, Diskin R, Abadir A, et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012; 492:118 - 22; http://dx.doi.org/10.1038/nature11604; PMID: 23103874
   PubMed Web of Science ®Google Scholar
• Friedman LM, Rinon A, Schechter B, Lyass L, Lavi S, Bacus SS, Sela M, Yarden Y. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc Natl Acad Sci U S A 2005; 102:1915 - 20; http://dx.doi.org/10.1073/pnas.0409610102; PMID: 15684082
   PubMed Web of Science ®Google Scholar
• Marks JD. Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization. Mov Disord 2004; 19:Suppl 8 S101 - 8; http://dx.doi.org/10.1002/mds.20023; PMID: 15027061
   PubMed Web of Science ®Google Scholar
• Both L, Banyard AC, van Dolleweerd C, Horton DL, Ma JK, Fooks AR. Passive immunity in the prevention of rabies. Lancet Infect Dis 2012; 12:397 - 407; http://dx.doi.org/10.1016/S1473-3099(11)70340-1; PMID: 22541629
   PubMed Web of Science ®Google Scholar
• de Kruif J, Kramer A, Nijhuis R, van der Zande V, den Blanken R, Clements C, Visser T, Keehnen R, den Hartog M, Throsby M, et al. Generation of stable cell clones expressing mixtures of human antibodies. Biotechnol Bioeng 2010; 106:741 - 50; http://dx.doi.org/10.1002/bit.22763; PMID: 20564612
   PubMed Web of Science ®Google Scholar
• Weidle UH, Tiefenthaler G, Weiss EH, Georges G, Brinkmann U. The intriguing options of multispecific antibody formats for treatment of cancer. Cancer Genomics Proteomics 2013; 10:1 - 18; PMID: 23382582
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Baer A, Müller C, Gregersen K, Mønster NT, Rasmussen SK, Weilguny D, Tolstrup AB. Single-batch production of recombinant human polyclonal antibodies. Mol Biotechnol 2010; 45:257 - 66; http://dx.doi.org/10.1007/s12033-010-9270-9; PMID: 20306237
   PubMed Web of Science ®Google Scholar
• Wiberg FC, Rasmussen SK, Frandsen TP, Rasmussen LK, Tengbjerg K, Coljee VW, Sharon J, Yang CY, Bregenholt S, Nielsen LS, et al. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng 2006; 94:396 - 405; http://dx.doi.org/10.1002/bit.20865; PMID: 16596663
   PubMed Web of Science ®Google Scholar
• Robak T, Windyga J, Trelinski J, von Depka Prondzinski M, Giagounidis A, Doyen C, Janssens A, Alvarez-Román MT, Jarque I, Loscertales J, et al. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood 2012; 120:3670 - 6; http://dx.doi.org/10.1182/blood-2012-06-438804; PMID: 22915649
   PubMed Web of Science ®Google Scholar
• Dorai H, Corisdeo S, Ellis D, Kinney C, Chomo M, Hawley-Nelson P, Moore G, Betenbaugh MJ, Ganguly S. Early prediction of instability of Chinese hamster ovary cell lines expressing recombinant antibodies and antibody-fusion proteins. Biotechnol Bioeng 2012; 109:1016 - 30; http://dx.doi.org/10.1002/bit.24367; PMID: 22068683
   PubMed Web of Science ®Google Scholar
• Barnes LM, Bentley CM, Dickson AJ. Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 2003; 81:631 - 9; http://dx.doi.org/10.1002/bit.10517; PMID: 12529877
   PubMed Web of Science ®Google Scholar
• Nehlsen K, Schucht R, da Gama-Norton L, Krömer W, Baer A, Cayli A, Hauser H, Wirth D. Recombinant protein expression by targeting pre-selected chromosomal loci. BMC Biotechnol 2009; 9:100; http://dx.doi.org/10.1186/1472-6750-9-100; PMID: 20003421
   PubMed Web of Science ®Google Scholar
• Henckaerts E, Linden RM. Adeno-associated virus: a key to the human genome?. Future Virol 2010; 5:555 - 74; http://dx.doi.org/10.2217/fvl.10.48; PMID: 21212830
   PubMed Web of Science ®Google Scholar
• Hüser D, Gogol-Döring A, Lutter T, Weger S, Winter K, Hammer EM, Cathomen T, Reinert K, Heilbronn R. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog 2010; 6:e1000985; http://dx.doi.org/10.1371/journal.ppat.1000985; PMID: 20628575
   PubMedGoogle Scholar
• Janovitz T, Klein IA, Oliveira T, Mukherjee P, Nussenzweig MC, Sadelain M, Falck-Pedersen E. High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration. J Virol 2013; 87:8559 - 68; http://dx.doi.org/10.1128/JVI.01135-13; PMID: 23720718
   PubMed Web of Science ®Google Scholar
• Balagúe C, Kalla M, Zhang WW. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol 1997; 71:3299 - 306; PMID: 9060699
   PubMed Web of Science ®Google Scholar
• Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K, Natsoulis G. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 1997; 71:7951 - 9; PMID: 9311886
   PubMed Web of Science ®Google Scholar
• Guilbaud M, Chadeuf G, Avolio F, François A, Moullier P, Recchia A, Salvetti A. Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration. J Virol 2008; 82:2590 - 3; http://dx.doi.org/10.1128/JVI.01956-07; PMID: 18094174
   PubMed Web of Science ®Google Scholar
• Philpott NJ, Giraud-Wali C, Dupuis C, Gomos J, Hamilton H, Berns KI, Falck-Pedersen E. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J Virol 2002; 76:5411 - 21; http://dx.doi.org/10.1128/JVI.76.11.5411-5421.2002; PMID: 11991970
   PubMed Web of Science ®Google Scholar
• Urabe M, Kogure K, Kume A, Sato Y, Tobita K, Ozawa K. Positive and negative effects of adeno-associated virus Rep on AAVS1-targeted integration. J Gen Virol 2003; 84:2127 - 32; http://dx.doi.org/10.1099/vir.0.19193-0; PMID: 12867644
   PubMed Web of Science ®Google Scholar
• Lai T, Yang Y, Ng SK. Advances in Mammalian cell line development technologies for recombinant protein production. Pharmaceuticals (Basel) 2013; 6:579 - 603; http://dx.doi.org/10.3390/ph6050579; PMID: 24276168
   PubMedGoogle Scholar
• Ye J, Alvin K, Latif H, Hsu A, Parikh V, Whitmer T, Tellers M, de la Cruz Edmonds MC, Ly J, Salmon P, et al. Rapid protein production using CHO stable transfection pools. Biotechnol Prog 2010; 26:1431 - 7; http://dx.doi.org/10.1002/btpr.469; PMID: 20564356
   PubMed Web of Science ®Google Scholar
• Holmes D. Buy buy bispecific antibodies. Nat Rev Drug Discov 2011; 10:798 - 800; http://dx.doi.org/10.1038/nrd3581; PMID: 22037028
   PubMed Web of Science ®Google Scholar
• Rasmussen SK, Næsted H, Müller C, Tolstrup AB, Frandsen TP. Recombinant antibody mixtures: production strategies and cost considerations. Arch Biochem Biophys 2012; 526:139 - 45; http://dx.doi.org/10.1016/j.abb.2012.07.001; PMID: 22820097
   PubMed Web of Science ®Google Scholar
• Rasmussen SK, Nielsen LS, Muller C, Bouquin T, Naested H, Monster NT, Nygaard F, Weilguny D, Frandsen TP, Tolstrup AB. Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes. BMC proceedings 2011; 5 Suppl 8:O2.
   Google Scholar
• Frandsen TP, Naested H, Rasmussen SK, Hauptig P, Wiberg FC, Rasmussen LK, Jensen AM, Persson P, Wikén M, Engström A, et al. Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use. Biotechnol Bioeng 2011; 108:2171 - 81; http://dx.doi.org/10.1002/bit.23166; PMID: 21495017
   PubMed Web of Science ®Google Scholar
• Lamartina S, Roscilli G, Rinaudo D, Delmastro P, Toniatti C. Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle. J Virol 1998; 72:7653 - 8; PMID: 9696870
   PubMed Web of Science ®Google Scholar
• Howden SE, Voullaire L, Vadolas J. The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration. J Gene Med 2008; 10:42 - 50; http://dx.doi.org/10.1002/jgm.1118; PMID: 18001001
   PubMed Web of Science ®Google Scholar
• Poste G, Doll J, Fidler IJ. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci U S A 1981; 78:6226 - 30; http://dx.doi.org/10.1073/pnas.78.10.6226; PMID: 6947225
   PubMed Web of Science ®Google Scholar
• Philpott NJ, Gomos J, Berns KI, Falck-Pedersen E. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci U S A 2002; 99:12381 - 5; http://dx.doi.org/10.1073/pnas.182430299; PMID: 12221283
   PubMed Web of Science ®Google Scholar
• P[UNKNOWN ENTITY &odie;]rtner R. Animal cell biotechnology: methods and protocols. Totowa, NJ: Humana Press, 2007.
   Google Scholar